Form 4 for SVRA Savara Inc
Accepted 2025-12-04 00:00:00 ET · period of report 2025-12-04 · accession 0001193125-25-308325 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-04 | 2025-12-04 | SVRA | Wasfi Yasmine | Chief Medical Off | F - Tax | $6.37 | -22.0K | 168.0K | -12% | -$140.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-04 | F | D | 21,992 | $6.37 | 168,008 | D | — | — | (F1) Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units. |